Dupilumab efficacy by disease severity in pediatric type 2 asthma
Pediatr Allergy Immunol. 2025 Nov;36(11):e70196. doi: 10.1111/pai.70196. ABSTRACT BACKGROUND: Dupilumab demonstrated efficacy in children with asthma in phase 3 VOYAGE (NCT02948959) and open-label extension EXCURSION …